AEGON - Summary of Annual General Meeting of Shareholders

All Resolutions of the Annual General Meeting of Shareholders Adopted

THE HAGUE, The Netherlands, May 12, 2011 - Resolutions of the 2011 Annual General Meeting of Shareholders*

The decisions made by the shareholders at the 2011 Annual General Meeting
of Shareholders (AGM) include the following:

Reappointments

Mr. Alex Wynaendts was reappointed as a member of the Executive Board for
another term of four years as of May 12, 2011.

Mr. Antony Burgmans, Mrs. Karla Peijs and Mr. Leo van Wijk were
reappointed as members of the Supervisory Board for another term of four
years as of May 12, 2011.

Dividend

AEGON will not pay a dividend on its common shares over 2010.

Annual accounts

The AGM adopted the annual accounts for the financial year 2010 and the
members of the Executive Board and Supervisory Board were released from
liability for their duties.

Authorizations Executive Board

The AGM authorized the Executive Board to issue common shares, to
restrict/exclude pre-emptive rights upon issuing common shares, to issue
common shares under incentive plans and to acquire shares in the company.

Appointment independent auditor

Ernst & Young was appointed as the independent auditor for the Annual
Accounts 2011.

Adjustments Executive Board Remuneration Policy adopted

The adjustments to the Remuneration Policy for the members of the
Executive Board were adopted. The adjustments will take effect from January
1, 2011.

*The full details of the resolutions approved during the shareholders'
meeting may be found in the 2011 AGM section at AEGON's corporate website:
www.aegon.com/Home/Investors/Publications/AGM/

About AEGON

As an international life insurance, pension and asset management company
based in The Hague, AEGON has businesses in over twenty markets in the
Americas, Europe and Asia. AEGON companies employ approximately 27,500 people
and have some 40 million customers across the globe.

    Key figures - EUR        Q1 2011    Full year 2010

    Underlying earnings
    before tax            414 million    1.8 billion
    New life sales        501 million    2.1 billion
    Gross deposits        7.4 billion     33 billion
    Revenue-generating
    Investments
    (end of period)       400 billion    413 billion

Forward-looking statements

The statements contained in this document that are not historical facts
are forward-looking statements as defined in the US Private Securities
Litigation Reform Act of 1995. The following are words that identify such
forward-looking statements: aim, believe, estimate, target, intend, may,
expect, anticipate, predict, project, counting on, plan, continue, want,
forecast, goal, should, would, is confident, will, and similar expressions as
they relate to our company. These statements are not guarantees of future
performance and involve risks, uncertainties and assumptions that are
difficult to predict. We undertake no obligation to publicly update or revise
any forward-looking statements. Readers are cautioned not to place undue
reliance on these forward-looking statements, which merely reflect company
expectations at the time of writing. Actual results may differ materially
from expectations conveyed in forward-looking statements due to changes
caused by various risks and uncertainties. Such risks and uncertainties
include but are not limited to the following:

- Changes in general economic conditions, particularly in the United
States, the Netherlands and the United Kingdom;

- Changes in the performance of financial markets, including emerging
markets, such as with regard to:

- The frequency and severity of defaults by issuers in our fixed income
investment portfolios; and

- The effects of corporate bankruptcies and/or accounting restatements on
the financial markets and the resulting decline in the value of equity and
debt securities we hold;

- The frequency and severity of insured loss events;

- Changes affecting mortality, morbidity, persistence and other factors
that may impact the profitability of our insurance products;

- Changes affecting interest rate levels and continuing low or rapidly
changing interest rate levels;

- Changes affecting currency exchange rates, in particular the EUR/USD
and EUR/GBP exchange rates;

- Increasing levels of competition in the United States, the Netherlands,
the United Kingdom and emerging markets;

- Changes in laws and regulations, particularly those affecting our
operations, the products we sell, and the attractiveness of certain products
to our consumers;

- Regulatory changes relating to the insurance industry in the
jurisdictions in which we operate;

- Acts of God, acts of terrorism, acts of war and pandemics;

- Changes in the policies of central banks and/or governments;

- Lowering of one or more of our debt ratings issued by recognized rating
organizations and the adverse impact such action may have on our ability to
raise capital and on our liquidity and financial condition;

- Lowering of one or more of insurer financial strength ratings of our
insurance subsidiaries and the adverse impact such action may have on the
premium writings, policy retention, profitability of its insurance
subsidiaries and liquidity;

- The effect of the European Union's Solvency II requirements and other
regulations in other jurisdictions affecting the capital we are required to
maintain;

- Litigation or regulatory action that could require us to pay
significant damages or change the way we do business;

- Customer responsiveness to both new products and distribution channels;

- Competitive, legal, regulatory, or tax changes that affect the
distribution cost of or demand for our products;

- The impact of acquisitions and divestitures, restructurings, product
withdrawals and other unusual items, including our ability to integrate
acquisitions and to obtain the anticipated results and synergies from
acquisitions;

- Our failure to achieve anticipated levels of earnings or operational
efficiencies as well as other cost saving initiatives;

- Our inability to obtain consent from the Dutch Central Bank to
repurchase our Core Capital Securities; and

- The non-fulfillment of the conditions precedent underlying the
agreement to divest Transamerica Reinsurance.

Further details of potential risks and uncertainties affecting the
company are described in the company's filings with Euronext Amsterdam and
the US Securities and Exchange Commission, including the Annual Report on
Form 20-F. These forward-looking statements speak only as of the date of this
document. Except as required by any applicable law or regulation, the company
expressly disclaims any obligation or undertaking to release publicly any
updates or revisions to any forward-looking statements contained herein to
reflect any change in the company's expectations with regard thereto or any
change in events, conditions or circumstances on which any such statement is
based.

    Contact information

    Media relations:
    Greg Tucker
    +31(0)70-344-8956
    gcc-ir@aegon.com

    Investor relations:
    Willem van den Berg
    +31(0)70-344-8305
    877-548-9668 - toll free USA only
    ir@aegon.com

    www.aegon.com

PRN NLD

.